Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform [Yahoo! Finance]
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.
Nautilus Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]